ALGS Stock Analysis: Buy, Sell, or Hold?
ALGS - Aligos Therapeutics, Inc. Common Stock
$6.56
0.05 (0.77%)
▲
5d:
-24.94%
30d:
-3.67%
90d:
-18.1%
WAIT
LOW Confidence
Analysis Updated: Apr 21, 2026 12:00 AM ET
Earnings: May 05, 2026
12d
Get Alerted When ALGS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: ALGS is down 24.9% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: ALGS is down 24.9% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: ALGS is currently trading at $6.56, which is considered oversold relative to its 30-day fair value range of $6.87 to $8.01.
Technical Outlook: Technically, ALGS is in a downtrend. Immediate support is located at $6.21, while resistance sits at $8.97.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $65.80 (+903.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ALGS is in a downtrend. Immediate support is located at $6.21, while resistance sits at $8.97.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $65.80 (+903.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$6.87 -
$8.01
Company Quality Score
54/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
77.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: Trading 903.0% below Wall St target ($65.80)
- WARNING: Recommendation downgraded due to -24.9% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$6.87 -
$8.01
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$6.21
Resistance Level
$8.97
Current Trend
Downtrend
Technical data as of
Apr 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.35
Wall Street Target
$65.80
(+903.0%)
Revenue Growth (YoY)
-73.1%
Share & Embed Analysis
Last updated: April 22, 2026 4:05 AM ET
Data refreshes hourly during market hours. Next update: 5:05 AM
Data refreshes hourly during market hours. Next update: 5:05 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ALGS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1034 | 64 BUY |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$83 | 58 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
19 analysts |
$212 | 56 HOLD |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$294 | 58 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$8 | 52 HOLD |
